FDA
approval
· 2023-10-24
FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
Summary
The FDA approved a supplemental application for ziprasidone hydrochloride from BluePoint Laboratories, granting ANDA-based approval of a generic form of ziprasi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ZIPRASIDONE HYDROCHLORIDE (ZIPRASIDONE HYDROCHLORIDE)